Biguanides

Results: 159



#Item
121Microsoft Word - Cleared version of Glucovance BPCA Drug Use Review D030616.

Microsoft Word - Cleared version of Glucovance BPCA Drug Use Review D030616.

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2005-02-11 16:13:37
122HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use PrandiMet safely and effectively. See full prescribing information for PrandiMet. PrandiMet® (repaglinide and metfo

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use PrandiMet safely and effectively. See full prescribing information for PrandiMet. PrandiMet® (repaglinide and metfo

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2012-03-06 13:54:12
123HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use JANUMET safely and effectively. See full prescribing information for JANUMET. JANUMET® (sitagliptin/metformin HCl)

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use JANUMET safely and effectively. See full prescribing information for JANUMET. JANUMET® (sitagliptin/metformin HCl)

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2012-10-22 15:47:59
124Choosing a type 2 diabetes drug Why generic metformin is often the best choice D iabetes makes your blood sugar get too high.

Choosing a type 2 diabetes drug Why generic metformin is often the best choice D iabetes makes your blood sugar get too high.

Add to Reading List

Source URL: consumerhealthchoices.org

Language: English - Date: 2013-06-15 16:54:42
125ACTOPLUS MET® (pioglitazone hydrochloride and metformin hydrochloride) tablets WARNING: CONGESTIVE HEART FAILURE  Thiazolidinediones, including pioglitazone, which is a component of ACTOPLUS MET, cause or exacerbate

ACTOPLUS MET® (pioglitazone hydrochloride and metformin hydrochloride) tablets WARNING: CONGESTIVE HEART FAILURE  Thiazolidinediones, including pioglitazone, which is a component of ACTOPLUS MET, cause or exacerbate

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2011-08-04 14:45:15
126HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use JANUMET safely and effectively. See full prescribing information for JANUMET. 

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use JANUMET safely and effectively. See full prescribing information for JANUMET. 

Add to Reading List

Source URL: www.merck.com

Language: English - Date: 2014-02-11 11:56:37
127HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INVOKANA® safely and effectively. See full prescribing information for INVOKANA. INVOKANA (canagliflozin) tablets,

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INVOKANA® safely and effectively. See full prescribing information for INVOKANA. INVOKANA (canagliflozin) tablets,

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-05-21 09:30:40
128Kombiglyze XR medication guide

Kombiglyze XR medication guide

Add to Reading List

Source URL: www.fda.gov

Language: English
129HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use KOMBIGLYZE XR safely and effectively. See full prescribing information for KOMBIGLYZE XR. •

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use KOMBIGLYZE XR safely and effectively. See full prescribing information for KOMBIGLYZE XR. •

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2013-06-04 11:53:49
130HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use JENTADUETO safely and effectively. See full prescribing information for JENTADUETO. Jentadueto® (linagliptin and me

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use JENTADUETO safely and effectively. See full prescribing information for JENTADUETO. Jentadueto® (linagliptin and me

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-05-27 14:10:03